Castleview Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Castleview Partners's AMGN Position: Q2 2026 in Review
Castleview Partners increased its Amgen (AMGN) stake by 34% in Q2 2026, buying an estimated $922K and bringing the position to 10,552 shares worth $3.82M. The position accounts for 1.68% of the portfolio, ranked #12.
Castleview Partners first reported a position in AMGN in Q2 2021 and has held it in 19 quarters since. The position peaked at $4.13M in Q4 2025. 1,303 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Castleview Partners held 10,552 shares of Amgen worth $3.82M as of Q2 2026.
- Castleview Partners bought 2,692 Amgen shares in Q2 2026, an estimated $922K.
- Amgen made up 1.68% of Castleview Partners's portfolio in Q2 2026, its #12 holding.
- Castleview Partners first reported a position in Amgen in Q2 2021 and has held it in 19 quarters since.
- Castleview Partners's Amgen position peaked at $4.13M in Q4 2025.
- 1,303 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.